Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹590 Cr₹611 Cr₹1,695 Cr₹358 Cr₹93 Cr

What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹590 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹590 Cr
Mar2024₹611 Cr
Mar2023₹1,695 Cr
Mar2022₹358 Cr
Mar2021₹93 Cr

How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹590 Cr
-3.39
Mar2024 ₹611 Cr
-63.97
Mar2023 ₹1,695 Cr
373.19
Mar2022 ₹358 Cr
284.26
Mar2021 ₹93 Cr -

Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,090.8 Cr -2.7% -0.1% 9.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-2.7%

-0.1%

9.4%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses